"Adjuvant Immunization of HLA-A2-Positive Melanoma Patients With a Modified gp100 Peptide Induces Peptide-Specific CD8+ T-Cell Responses" by John W. Smith

Selected Works of Walter J. Urba, MD, PhD

Article

Adjuvant Immunization of HLA-A2-Positive Melanoma Patients With a Modified gp100 Peptide Induces Peptide-Specific CD8+ T-Cell Responses

Journal of Clinical Oncology (2003)

John W. Smith, Loyola University Chicago
Edwin B. Walker, Providence Portland Medical Center
Bernard A. Fox, Providence Portland Medical Center
Daniel Haley, Providence Regional Medical Center Everett
Ketura P. Wisner, Providence Portland Medical Center
Teri Doran, Providence Portland Medical Center
Brenda Fisher, Providence Portland Medical Center
Lisa Justice
William Wood, Emory University
John Vetto, Oregon Health & Science University
Holden Maecker, Becton Dickinson
Annemiek Dols
Sybren Meijer, VU University Amsterdam
Hong Ming Hu, Providence Portland Medical Center
Pedro Romero, Ludwig Institute for Cancer Research
W. Gregory Alvord, National Institutes of Health
Walter J. Urba, Providence Portland Medical Center

Link

Disciplines

Publication Date

April 15, 2003

DOI

10.1200/JCO.2003.09.020

Citation Information

John W. Smith, Edwin B. Walker, Bernard A. Fox, Daniel Haley, et al.. "Adjuvant Immunization of HLA-A2-Positive Melanoma Patients With a Modified gp100 Peptide Induces Peptide-Specific CD8+ T-Cell Responses" Journal of Clinical Oncology Vol. 21 Iss. 8 (2003) p. 1562 - 1573
Available at: http://works.bepress.com/walter-urba/216/